Navigation Links
Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR

BOTHELL, Wash. & LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - Seattle Genetics, Inc. (Nasdaq: SGEN) today announced data from fifteen presentations by the company and its collaborators at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) demonstrating preclinical advances with its proprietary antibody-drug conjugate (ADC) technology and cancer product pipeline.

ADCs are monoclonal antibodies linked to cell-killing drugs. Seattle Genetics' ADC technology employs synthetic, highly potent drugs that are bound to monoclonal antibodies through proprietary linker systems. The linkers are designed to be stable in the bloodstream but to release the drug payload under specific conditions once inside target cells, thereby sparing non-target cells many of the toxic effects of traditional chemotherapy.

"Empowered antibodies utilizing our ADC technology have the potential to significantly impact the way cancer is treated," said Clay B. Siegall, Ph.D., President and Chief Executive Officer at Seattle Genetics. "Our strong presence at AACR this year reflects continued progress with our proprietary and partnered ADC programs. We expect to report clinical data from the ongoing phase I dose-escalation trial of SGN-35, our lead ADC, later this year, while both we and our collaborators continue to advance additional ADC programs into and towards the clinic."

ADC Programs

Researchers reported preclinical data at AACR describing how changes in the structure of the attached drugs can affect ADC efficacy and tolerability, the impact that linker structure and these modifications can have on ADC activity, and the ability of Seattle Genetics' ADC technology to effectively deliver active drugs to target tissue while avoiding non-targeted drug release. (Abstracts #4793, #916 and #4088) Further data from preclinical models of ADCs provide mechanistic insight into how and when drugs are r
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
2. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
3. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
6. Myriad Genetics Presents Tumor Origin Technology at AACR
7. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
8. Myriad Genetics Presents Azixas Mode of Action at AACR
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

Post Your Comments:
(Date:11/6/2009)...- Trius Therapeutics, Inc. announced today that it...th the U.S. Securities and Exchange Commission (SE...of shares of its common stock. All shares of the c...ered by the Company. ,, Credit Suisse Securitie..., Piper Jaffray & Co. is acting as co-lead man...
(Date:11/6/2009)...re-FirstCall/ -- Roper Industries, Inc. (NYSE: R...ive agreement to acquire Verathon, Inc., a leading...athon Board of Directors has approved the transact...tory approvals and closing conditions, including s...ng to be completed in early December. ,, Headq...
(Date:11/6/2009)...ire-FirstCall/ -- Derma Sciences, Inc. (OTC Bu...care products, announced plans to release its thir...vember 16, 2009. The Company will hold a conferenc...00 am EST. Interested parties should call (866) 78...), with passcode 81416481 to access the call. You ...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Genes may explain why children who live without dads have earlier sex 9923 1Genes may explain why children who live without dads have earlier sex 9923 2The Pancreatic Cancer Action Network Is Saddened by the Death of Actor Patrick Swayze 57133 1The Pancreatic Cancer Action Network Is Saddened by the Death of Actor Patrick Swayze 57133 2Molecules on a string and why size isnt the only thing that matters for data storage 14038 1Molecules on a string and why size isnt the only thing that matters for data storage 14038 2
...ship under LLS,s Therapy Acceleration Program to A...Myelogenous Leukemia, WHITE PLAINS, N.Y., April 1... Group, Inc. today jointly announced the execution...t funded through LLS,s,Therapy Acceleration Progra...on to accelerate the development,of a fusion toxin...
...ss., April 16 Repligen Corporation,(Nasdaq: RGEN...inistration,(FDA) has granted Fast Track designati...c human secretin, to improve the assessment of pan...ing (MRI). Fast track is a,process designed to fac...,drugs that treat serious diseases and fill an unm...
Other Medicine Technology:The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement 2The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement 3Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging 2Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging 3Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging 4
(Date:11/8/2009)... , "One victory does not mean the battle is ... Nov. 7 In a vote of 24...r-Lipinski-Smith Amendment to prohibit abortion ma...floor. ,, Americans United for Life Action Pres...ge of this amendment is a victory for the pro-life...
(Date:11/8/2009)... , WASHINGTON, Nov. 7 /PRNewswire-USNewswire/...fordable Health Care for America Act, which will m...d insurance companies accountable and increase acc...gh a public option. ,, "Teddy Roosevelt, FDR an...ram Director Alan Charney. "Today,s vote ranks amo...
(Date:11/8/2009)... , Calls for Swift Passage of H.R. 3961 to S...v. 7 Statement Attribut...n Medical Association. ,, (Logo: http://www.n... "The AMA hails the passage of the House health re...em for patients and physicians and calls for swift...
(Date:11/8/2009)... , AARP Praises House Passage of Health Care...rengthen Medicare, improve coverage for all Americ... -- Today, the United States House of Representati...are reform legislation that would strengthen Medic...e companies that prices millions of Americans out ...
(Date:11/8/2009)... , AARP Praises House Passage of Health Care...rengthen Medicare, improve coverage for all Americ...e/ -- SUMMARY: Tonight the United States House o...rm legislation that would strengthen Medicare for ...ies that prices millions of Americans out of affor...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3
...ano’s bestseller ‘French Women Don’t Get Fat’ may ...es, 5.9 million of France's 63.4 million// people ...igures have got the French government scratching t... down hard on junk food advertisements. Such adver...
...wance of ?9,000 per year will be given to dentists...Scotland//. This was announced by the Scottish Exe...re will enjoy this special allowance. This scheme ...area. Craigmiller is the poorest area when income ...
... of bread available in the supermarket were found ...s the Consensus Action// on Salt and Health (Cash)...f them contained more salt than the Food Standards...as found that some brands were so salty that nine ...
...s of China and France signed a landmark cooperativ...aditional// Chinese medicine (TCM) expected by pra...ancer. The two countries will cooperate in a...the document signed by Chinese Health Minister Gao...
...a's Fujian province was on high alert after it con...Thursday//. Zhang Changpin, vice governor of F... to prevent an outbreak of the epidemic. He asked ... in Jian'ou city, developed symptoms of fever, cou...
...sts say a simple test can identify men at high ris... biopsy finds no signs of it//. The key, researche...of a man's prostate with his levels of a cancer-re...ancers than men with lower scores in an Oregon stu...
Other Medicine News:Health News:Too Much of Salt in Bread.. 2Health News:Scientists Tout New Prostate Cancer Test 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: